Inventor · disambiguated record
Joost Alexander Kolkman
Also filed as: KOLKMAN JOOST · KOLKMAN JOOST A · KOLKMAN JOOST ALEXANDER
21 granted patents·28 pending applications·165 citations·filing 2002–2024
95Inventor score
Files withABLYNX NV13AVIDIA RES INST8BOEHRINGER INGELHEIM INT7JANSSEN VACCINES & PREVENTION BV3MERCK PATENT GMBH3
Top patents by PatentIndex Score
49 records- 0195US10786568B2AAV mediated influenza vaccinesUNIV PENNSYLVANIA·Filed 2018·Granted Sep 29, 2020·16 cites·18 claims
- 0295US8629244B2Interleukin-6 receptor binding polypeptidesKOLKMAN JOOST ALEXANDER·Filed 2007·Granted Jan 14, 2014·51 cites·22 claims
- 0392US8962805B2Anti IL-6R polypeptides and compositions thereofABLYNX NV·Filed 2014·Granted Feb 24, 2015·14 cites·19 claims
- 0491US9273150B2Methods of using IL-6R antibodies to block or reduce binding of IL-6 to IL-6RABLYNX NV·Filed 2014·Granted Mar 1, 2016·11 cites·16 claims
- 0591US8748581B2Anti-IL-6R polypeptides and pharmaceutical compositions thereofBEIRNAERT ELS ANNA ALICE·Filed 2010·Granted Jun 10, 2014·15 cites·11 claims
- 0690US9181350B2Nucleic acids encoding IL-6R-binding polypeptidesABLYNX NV·Filed 2014·Granted Nov 10, 2015·10 cites·23 claims
- 0789US9605072B2Nucleic acids that encode interleukin-6 receptor binding polypeptidesABLYNX NV·Filed 2014·Granted Mar 28, 2017·8 cites·42 claims
- 0888US9611326B2Interleukin-6 receptor binding polypeptidesABLYNX NV·Filed 2013·Granted Apr 4, 2017·7 cites·22 claims
- 0987US10370435B2Binding molecules directed against influenza hemagglutinin and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2016·Granted Aug 6, 2019·6 cites·9 claims
- 1087US9617341B2Methods for blocking or reducing binding of interleukin-6 to interleukin-6 receptorABLYNX NV·Filed 2014·Granted Apr 11, 2017·7 cites·34 claims
- 1186US10618966B2Methods for the treatment of interleukin-6 receptor-related diseases and disordersABLYNX NV·Filed 2017·Granted Apr 14, 2020·2 cites·18 claims
- 1285US2024141030A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1384US10392440B2Methods for the preparation of compounds directed against interleukin-6 receptor (IL-6R)ABLYNX NV·Filed 2016·Granted Aug 27, 2019·3 cites·12 claims
- 1481US10703804B2Binding molecules directed against influenza hemagglutinin and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2019·Granted Jul 7, 2020·1 cites·22 claims
- 1581US9670275B2Sequences directed against hepatocyte growth factor (HGF) and polypeptides comprising the same for the treatment of cancers and/or tumorsABLYNX NV·Filed 2013·Granted Jun 6, 2017·3 cites·8 claims
- 1680US10829552B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using sameMERCK PATENT GMBH·Filed 2018·Granted Nov 10, 2020·1 cites·14 claims
- 1779US2022363744A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1878US9120855B2Biologic compounds directed against death receptor 5CROMIE KAREN·Filed 2011·Granted Sep 1, 2015·7 cites·17 claims
- 1976US10017568B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and method of treatment using sameROMMELAERE HEIDI·Filed 2012·Granted Jul 10, 2018·3 cites·13 claims
- 2074US2022195031A1Amino acid sequences directed against il-17a, il-17f and/or il-17a/f and polypeptides comprising the sameMERCK PATENT GMBH·Filed 2022·Application pending·0 cites
- 2172US11773159B2Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using sameMERCK PATENT GMBH·Filed 2020·Granted Oct 3, 2023·0 cites·15 claims
- 2270US11136379B2Binding molecules directed against influenza hemagglutinin and uses thereofJANSSEN VACCINES & PREVENTION BV·Filed 2020·Granted Oct 5, 2021·0 cites·17 claims
- 2370US2020308267A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 2463US2005221384A1Combinatorial libraries of monomer domainsMAXYGEN INC·Filed 2004·Application pending·0 cites
- 2562US2010216663A1Novel proteins with targeted bindingAMGEN MOUNTAIN VIEW INC·Filed 2009·Application pending·0 cites
- 2661US2018201671A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 2760US2005089932A1Novel proteins with targeted bindingAVIDIA RES INST·Filed 2004·Application pending·0 cites
- 2858US2020390888A1Novel aav mediated influenza vaccinesUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 2957US10100110B2Sequences directed against hepatocyte growth factor (HGF) and polypeptides comprising the same for the treatment of cancers and/or tumorsABLYNX NV·Filed 2017·Granted Oct 16, 2018·0 cites·8 claims
- 3057US2010204052A1Protein scaffolds and uses thereofAMGEN INC·Filed 2009·Application pending·0 cites
- 3155US2005164301A1LDL receptor class A and EGF domain monomers and multimersAVIDIA RES INST·Filed 2004·Application pending·0 cites
- 3255US2016200806A1Vegf-binding moleculesBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 3354US2005053973A1Novel proteins with targeted bindingAVIDIA RES INST·Filed 2004·Application pending·0 cites
- 3453US2006286603A1Combinatorial libraries of monomer domainsAVIDIA RES INST·Filed 2006·Application pending·0 cites
- 3552US2012225081A1Vegf-binding moleculesGSCHWIND ANDREAS·Filed 2011·Application pending·0 cites
- 3651US2015259426A1Biologic compoundsNOVARTIS AG·Filed 2014·Application pending·0 cites
- 3749US10214588B2Providing improved immunoglobulin sequences by mutating CDR and/or FR positionsKOLKMAN JOOST ALEXANDER·Filed 2008·Granted Feb 26, 2019·0 cites·5 claims
- 3848US2009286727A1DP-78-Like NanobodiesABLYNX NV·Filed 2007·Application pending·0 cites
- 3948US2008267949A1Peptides capable of binding to serum proteinsABLYNX NV·Filed 2007·Application pending·0 cites
- 4047US2003082630A1Combinatorial libraries of monomer domainsMAXYGEN INC·Filed 2002·Application pending·0 cites
- 4147US2014120095A1Bispecific binding molecules for anti-angiogenesis therapyBORGES ERIC·Filed 2013·Application pending·0 cites
- 4246US2004175756A1Methods for using combinatorial libraries of monomer domainsAVIDIA RES INST·Filed 2003·Application pending·0 cites
- 4346US2011059101A9Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated SignallingABLYNX NV·Filed 2007·Application pending·0 cites
- 4445US2006223114A1Protein scaffolds and uses thereofAVIDIA RES INST·Filed 2005·Application pending·0 cites
- 4545US2003157561A1Combinatorial libraries of monomer domainsFiled 2002·Application pending·0 cites
- 4643US2005048512A1Combinatorial libraries of monomer domainsAVIDIA RES INST·Filed 2003·Application pending·0 cites
- 4742US2011172398A1Bispecific binding molecules for anti-angiogenesis therapyBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 4836US2006234299A1Protein scaffolds and uses thereofAVIDIA RES INST·Filed 2005·Application pending·0 cites
- 4935US2011195494A1Dll4-binging moleculesBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →